BioSpace News Archive

InMed Pharmaceuticals Inc today announced that it has filed an international patent application demonstrating neuroprotection and enhanced neuronal function using a rare cannabinoid for the potential treatment of neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease and others.

Otonomy, Inc. today announced it will report financial results for the third quarter 2021 and provide a corporate update at 4:30 p.m. ET (1:30 p.m. PT) on November 10, 2021.

PharmaTher Holdings Ltd. is pleased to announce it has entered into a research collaboration agreement with Revive Therapeutics Ltd.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced record third-quarter 2021 financial results and increased both its full-year 2021 net sales and adjusted EBITDA guidance.

Intuity Medical, Inc. announced the availability of the POGO Automatic® Blood Glucose Monitoring System in the U.S. The product is the first and only FDA-cleared blood glucose monitor whose 10-test cartridge technology makes a glucose test possible with only the press of a button and without needing to carry separate test strips and lancets.

BridgeBio Pharma, Inc. today announced that the first patient has been dosed in CANaspire, its Phase 1/2 clinical trial of BBP-812, an investigational adeno-associated virus (AAV) 9 gene therapy for the treatment of Canavan disease.

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed ® Conference will take place virtually from November 8-9, 2021.

Rain Therapeutics Inc. today announced it will report financial results for the third quarter that ended September 30, 2021 and highlights of recent progress, on Wednesday, November 10, 2021.

Outlook Therapeutics, Inc. today announced that C. Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics, will present at the Eyecelerator@AAO 2021 Conference Retina Showcases being held in New Orleans, Louisiana.

aTyr Pharma, Inc. today announced that it will report third quarter 2021 financial results and provide a corporate update after the market close on Wednesday, November 10, 2021.